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A Touch-Communication Framework for Drug
Delivery Based on a Transient Microbot
System
Yifan Chen, Panagiotis Kosmas, Putri Santi Anwar, and Limin Huang
Abstract
Recent progress in bioresorbable radio frequency electronics and engineered bacteria has promised
the prospect of realizing transient microbot systems (TMS) for therapeutic applications. The inorganic
or organic miniature robots will dissolve into the human body after completing the required tasks
and cause no side-effect. In this paper, we propose a potential architecture of TMS for transporting
a pharmaceutical compound inside the body, and analyze the system using a micro-to-macro cross-
scale communication model. The remote controllability and tangibility of TMS essentially lead to a
“touch-communications” (TouchCom) paradigm. The externally maneuverable and trackable TMS are
responsible for the delivery of drug particles (information molecules in the TouchCom context). The
loading/injection and unloading of the drug correspond to the transmitting and receiving processes in the
TouchCom framework. Subsequently, we investigate simulation tools for the propagation and transient
characteristics of TMS in the blood vessels. We also define the propagation delay, path loss, as well
as angular and delay spectra of targeting intensity, which are parallel to their counterpart concepts in
the conventional wireless channel. Finally, our approach is illustrated with comprehensive simulation
studies of targeted drug delivery by using the proposed analytical framework integrating robotics and
communications at crossover lengthscales.
Index Terms
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I. INTRODUCTION
A. Background and Motivation
In his seminal lecture “There’s Plenty of Room at the Bottom” in 1959 [1], Feynman presented
the revolutionary idea of building tiny, swallowable robots for medical applications. The talk laid the
conceptual foundations for the micro/nanorobotics. The recent development of active semiconductors
exhibiting transient behavior [2], [3] can revolutionize research in microbotics. These systems offer
remarkable levels of functionalities and can physically disappear at prescribed times and at controlled
rates [3]. Furthermore, latest advances in biorobotics have promised the prospect of realizing flagellated
magnetotactic bacteria (MTB). The MTB are biodegradable and their lifespan is dependent on the
micro-environmental conditions such as the temperature of blood and the width of vasculature, which
is beneficial from the perspective of biocompatibility and safe in vivo operations. By combining the
concepts of miniature robots and degradable electronics/engineered bacteria, we can envisage transient
microbot systems (TMS), which are remotely controllable and biologically resorbable [4].
Targeted drug delivery aims at delivering a therapeutic agent or drug where medication is needed
without affecting other healthy parts of the human body [5]. This process can be viewed as a molecular
communication system that uses principles beyond classical electromagnetism [6]–[17]. An engineered
miniature transmitter releases small particles (information molecules through which messages are en-
coded) into a fluid propagation medium. The particles propagate by applying either passive (e.g., diffusion)
or active (e.g., with molecular motors) transport schemes, and are eventually received at a miniature
receiver, where messages are decoded. Under this framework, the drug particles are information carriers,
which deliver messages (healing actions) from the transmitter location (injection site) to the receiver
location (targeted site).
By integrating robotics and communications “at the bottom”, this work presents a TMS-assisted micro-
to-macro cross-scale communication model as an abstraction of targeted drug delivery in the human body.
Macroscopically maneuverable and trackable TMS are employed as the vehicles carrying drug particles
(i.e., information molecules). The TMS exist for medically useful time frames before gradually dissolving
into biofluids via resorption by the body, and their pathway represents the channel for information
exchange, and. The loading/injection and unloading of the therapeutic agent correspond to the transmitting
and receiving processes in the context of information exchange. In this way, a novel paradigm of touch
communications (TouchCom) is achieved, which provides a visual display of information flow such that
the external macro-unit (MAU) can control the movement of TMS by “touching” the tangible TMS-
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manoeuvring space with a guiding force.
The TMS-assisted TouchCom has the potential to simplify the requirements of previous molecular
communication models by taking into account that: (i) micro/nanomachines cannot process complex
information, perform heavy computation, or store large amounts of data; (ii) micro/nanomachines can-
not modify freely molecules or control accurately the molecule release/reception process for message
encoding/decoding; and (iii) there is no effective mechanism to account for uncertainties during the
propagation process, which can be caused by various mechanisms such as random Brownian motions,
irregular change of temperature or pH value, unexpected chemical reactions in the fluid environment,
random decomposition or degeneration of molecules, etc. By moving most operations to the MAU, the
TouchCom process only demands the simplest functionalities (sensing and manoeuvring) at the TMS.
Moreover, remote controllability and trackability of the TMS reduce propagation delay and environmental
uncertainty.
B. Main Contributions
The main contributions of the current work can be summarized as follows.
1) We propose a cross-scale system architecture to facilitate communications. Specifically, we present
the constituent elements of TMS and discuss the fundamental methodology used for information
transfer by establishing the useful analogy between the TouchCom and drug delivery. Subsequently,
we propose a novel channel description framework for the TouchCom by defining the quantities of
propagation delay, path loss, as well as angular and delay spectra of signal strength (i.e., amount of
drug delivered to the targeted site), which are parallel to their counterpart concepts in the traditional
wireless channel.
2) We propose simulation tools for the propagation and transient characteristics of a TMS swarm in
the blood vessels. The former is modeled using a fractal-based random walk process and the latter
is divided into three different components due to three different phenomena: diffusion, branching,
and degeneration.
3) We present the paradigm of TouchCom by applying the principle of “seeing-is-communicating”
to visualize the entire process of information transfer in real time. Consequently, we can adjust
adaptively the next movement of the TMS swarm “on the fly” based upon the previous observation
on the past trajectory of the swarm. Eventually, we propose a cognitive control engine to optimize
the performance of the TouchCom.
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Fig. 1. (a) Key functional elements of a TMS and (b) conceptual illustration of the TMS-oriented TouchCom model for targeted
drug delivery.
C. Organization of the Paper
The paper is organized as follows. In Sections II, we present the architecture of the proposed TMS-
oriented small-scale communications by establishing the analogy between the TouchCom and targeted
drug delivery. We then introduce various parameters to describe the TouchCom channel with this anal-
ogy in mind. In Section III, we analyze the simulation tools to describe the movement and transient
characteristics of the TMS swarm, as well as the loading/unloading operations. In Section IV, we look
into cognitive design strategies for the proposed system. Finally, Section V provides comprehensive
simulation studies of targeted drug delivery to demonstrate the principles of the analytical framework,
with conclusions provided in Section VI.
II. TMS-ORIENTED TOUCHCOM
A. TMS Model Motivated by Experimental Findings
Water soluble and biocompatible constituent materials such as silicon nanomembranes, silicon dioxide
or magnesium oxide, and silk [2] have been used to manufacture radio frequency components such as
antennas, rectifying diodes, transistors, capacitors, inductors, resistors, ring oscillators, etc. Subsequently,
transient devices offering remarkable levels of functionalities such as sensors, actuators, power supplies,
and energy harvesting sub-systems have been achieved [3]. In addition, locomotiveness demanded in a
TMS can be accomplished with the manipulation of Lorentz forces on current-carrying wires based on
magnetohydrodynamics, or on asymmetries in fluid drag forces experienced by an oscillating structure
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TABLE I
ONE-TO-ONE CORRESPONDENCE BETWEEN TMS AND TRANSIENT ELECTRONICS OR MTB
TMS Transient Electronics MTB
Propeller Lorentz forces Flagellar bundles
Sensor Nanocircuit biosensors Receptor channels
Fuel Wireless power scavenger Nutrients-to-protons converter
Information molecules Nanocomposites Nanocomposites
Steering wheel Magnetohydrodynamics/asymmetric fluid drag steering Chains of magnetosomes
Navigator Passive or active positioning Passive or active positioning
[18]. The current technology can achieve mm-sized devices. Further miniaturization of various building
blocks can be realized with advancements in the fabrication processes and the constituent materials.
In addition to silicon-based systems, bacteria-based systems such as the biodegradable flagellated MTB
developed by Martel et al. [19]–[24] are also considered as possible TMS for our TouchCom paradigm.
The use of an MTB as a TMS has been discussed in our previous works [25], [26].
Nanocomposites can be loaded onto the TMS by utilizing biological or chemical bounding methods
[8]. The nanocomposites can also be functionalized by means of proper molecular groups such as peptides
or antibodies, which are able to bind to receptors at the unloading destination [8]. In order to deliver
sufficient amount of nanocomposites to a destination, a swarm of TMS can be injected simultaneously
[19], [20].
Based on these experimental findings, we have developed a conceptual model of a TMS [25], [26],
which comprises the functional elements depicted in Fig. 1(a) and listed in Table 1. It is worth noting
that, the navigator is implemented at the TMS, but the tracking operation is performed at the MAU, as
detailed in the next section. Either active or passive methods can be employed for navigation. In the
former case, information molecules could be labeled with fluorescent carbon nanotubes or quantum dots.
This procedure enables the nanocomposites to feed the location of the TMS swarm directly back to the
MAU [27], [28]. In the latter case, information molecules in the form of a microwave contrast agent
such as carbon nanotubes or ferroelectric nanoparticles can be employed. The nanocomposites do not
provide the position of the swarm explicitly. Instead, the MAU performs differential microwave imaging
to localize the swarm [25], [29]. The one-to-one correspondence between the TMS and the transient
electronics or MTB is illustrated in Table I.
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B. System Architecture of TouchCom
We illustrate the TMS-based TouchCom model for drug delivery in Fig. 1(b), where the information
molecules are theranostic agents. Nevertheless, the general framework is applicable to other user scenarios
such as monitoring and control of food and water qualities, NBC (nuclear, biological and chemical)
conditions, environmental pollution, etc. The loading/injection process is the binding of drug particles
to the TMS and the introduction of the TMS in the vascular network at a predefined injection site. We
abstract the loading/injection operation as the TouchCom transmitting process with ST δ(t) being the
transmitted signal, where ST is the number of injected particles attached to the TMS and δ(t) is the
Dirac delta function.
As illustrated in Fig. 1(b), the MAU can apply angiography to visualize partially the inside, or lumen,
of blood vessels in the human organ under examination and treatment. Current medical technologies can
achieve 0.3 mm resolution with the volume CT and less than 100 µm with the micro-CT [30]. The
MAU generates a magnetic field, and the TMS sense this field and move towards its gradient. While
continuous tracking of TMS could be achieved for active navigation mode, our approach is based on
defining intermediate aggregation zones (AZs), where the TMS are gathered to reduce diffusion and
branching losses.
Under passive navigation mode, the position of a TMS swarm is estimated upon arrival in an AZ,
resulting in “footprints” observed at the MAU. These are shown as circular red regions in Fig. 1(b).
During traveling to the AZs, the TMS swim at different velocities and as such they disperse, making the
density too low for tracking [19], [20]. Let’s consider, for example, the MTB studied in [19], [20], [25]. A
relatively weak magnetic field is generated towards an AZ, whose size can typically be in the millimeter
range. Assume that the boundary of the AZ corresponds to approximately 0.5 Gauss of magnetic field,
with the center at 0 Gauss. When outside the AZ, the MTB follow the line of magnetic field. When
inside the zone, the MTB are no longer influenced by magnetotaxis and begin random motions. If the
MTB exit the AZ, the magnetic field forces them to move back to the zone by magnetotaxis. We abstract
the propagation process [TMS footprints as shown in Fig. 1(b)] as the TouchCom channel, where the
transmitted signal is sent via the active transport scheme.
When the TMS reach the destination, the drug particles (information molecules) will be removed from
the vehicles and get assimilated into the targeted site allowing them to perform healing actions. As the
theranostic agent assists in the tracking operation, its binding to the targeted site deactivates the navigator
component. Subsequently, the location where the drug particles finally accumulate will give rise to a “sink”
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Fig. 2. Operation procedure of the proposed system.
on the visual display of the TMS propagation route. As the TMS are made of biodegradable electronics or
bacteria, they will dissolve in the blood after completing their tasks. We abstract the unloading operation
as the TouchCom receiving process with SRδ(t− τ) being the received signal, where SR is the number
of particles successfully discharged at the targeted site and τ is the propagation delay.
In summary, the main operations of TMS only involve propulsion and steering, which are achievable
with the current micro/nanobotic technologies. On the other hand, the complex operations of TMS control-
ling and positioning are performed at the macroscopic MAU. Furthermore, the small-scale communication
process is facilitated through a micro-to-macro system architecture. The operation procedure of the whole
system is illustrated in Fig. 2. Note that the loop incorporating both controlling and tracking steps underlies
the TouchCom principle to be elaborated in Section IV.
C. Description Methods for the TouchCom Channel
Structures of human vascular systems have been widely described using complex geometrical (fractal)
models according to principles of optimal network formation [31], [32]. The whole vascular tree is
approximated by a dichotomously branching system of tubes known as bifurcation as illustrated in Fig.
3. More details on the model of vasculature will be discussed in Section III-A. The signal observed at
the receiver has a random amplitude, delay, and angle due to the irregular vasculature. The directional
impulse response widely used in describing traditional wireless channels can be applied to the TouchCom
July 26, 2014 DRAFT
SUBMITTED TO IEEE TRANSACTIONS ON NANOBIOSCIENCE 7
Fig. 3. Propagation of TMS in the vascular tree and definitions of TouchCom channel parameters. The vascular tree is formed
of multiple bifurcating branches.
channel. Nevertheless, while traditional channels often exhibit multipath phenomena, the TouchCom
channel comprises only a single path, which can be expressed as
h(τ, ϕ) = h0δ (τ − τ0) δ (ϕ− ϕ0) . (1)
According to this model, the impulse response depends on three random variables, the path loss h0 =
SR/ST , the delay τ0 and the azimuth ϕ0. As illustrated in Fig. 3, we define a receiving circular zone,
representing the tumor microenvironment (microvasculature). The path loss h0 is caused by three different
signal attenuation mechanisms, namely, diffusion, branching, and degeneration, which can occur during
propagation of TMS from the injection site to the boundary of the receiving zone. The delay τ depends
on the propagation route and the speed of TMS. Finally, the azimuth ϕ is defined as the angle-of-arrival
at the receiving zone as depicted in Fig. 3.
As in the analysis of wireless channels, we can develop a spatial-temporal description of TouchCom
channels. The most fundamental quantity is the delay-azimuth spectrum, computed by averaging over all
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impulse responses:
Ξτ,ϕ(τ, ϕ) = αE
{
h
∣∣τ, ϕ} fτ,ϕ(τ, ϕ) = αE{h0∣∣τ0 = τ, ϕ0 = ϕ} fτ,ϕ(τ, ϕ), (2)
where E {·} denotes the expectation operator. The normalization factor α ensures that Ξτ,ϕ(τ, ϕ) is a
probability density function (pdf).
Following (2), the TouchCom channel azimuth spectrum and delay spectrum are derived as
Ξϕ(ϕ) =
∫
τ
Ξτ,ϕ(τ, ϕ)dτ =
∫
τ
αE
{
h0
∣∣τ0 = τ, ϕ0 = ϕ} fτ,ϕ(τ, ϕ)dτ, (3)
Ξτ (τ) =
∫
τ
Ξτ,ϕ(τ, ϕ)dϕ =
∫
ϕ
αE
{
h0
∣∣τ0 = τ, ϕ0 = ϕ} fτ,ϕ(τ, ϕ)dϕ. (4)
The formulations apply to the ensemble average of many spatial realizations of the vascular network,
such that the descriptions can be expressed as a continuous spectrum. The parameters in (3) and (4) are
parallel to the definitions of power azimuth spectrum and power delay spectrum in classical wireless
channels [33], [34].
We can also apply different ways to characterize the amount of TouchCom signal dispersion in the
spatial domain, which measures the width of azimuth spectrum. One approach follows the classical
definition in [34]:
σϕ =
√∫
ϕ
|exp(jϕ) − µϕ|2 Ξϕ(ϕ)dϕ, (5)
where
µϕ =
∫
ϕ
exp(jϕ)Ξϕ(ϕ)dϕ. (6)
Alternatively, if the azimuth spectrum has a symmetric shape with respect to the line-of-sight direction
(ϕ = 0◦), the angular spread can be defined as
σϕ =sup
{
ϕˆ ∈ [0, ϕmax] :
∫ ϕˆ
−ϕˆ
Ξϕ(ϕ)dϕ < ǫ
}
, (7)
where ϕmax is the maximum azimuth. This parameter defines the supremum limit of angular extent,
within which the percentage of received signal strength as compared to the total strength is less than a
sufficiently large value ǫ.
Suppose that the delay spectrum is a non-increasing function due to the increased path loss with delay.
The delay spread can be defined in a similar way to (7):
στ =sup
{
τˆ ∈ [τmin, τmax] :
∫ τˆ
−τˆ
Ξτ (τ)dτ < ǫ
}
, (8)
where τmin and τmax are the minimum and maximum delays.
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III. SIMULATION MODELS
We present simulation models of the movement and transient characteristics of a TMS swarm in
vasculature. We first look into the scenario when the blood vessels are resolvable on the angiogram. In
the last part of this section, we will describe the models when the blood vessels are angiographically
unresolvable.
A. Movement of TMS Swarm in Vasculature
In order to synthesize the movement of a TMS swarm in the blood vessels, a model to characterize
the vascular network should be constructed. Vasculature in the human body has two basic functions [31].
Firstly, the distributive function is to bring a stream of blood to every living cell within the body or organ
and is achieved by successive dichotomous division, or bifurcation. The self-similarity of bifurcation at
each node gives the vascular connection a fractal character. Secondly, the hemodynamic function is to
increase the cross-sectional area available to the blood flow in order to bring its velocity down to a level
sufficiently low to permit the exchange of metabolic products across the capillary wall. This function
governs the relationship between the diameter of the parent vessel and the diameters of two daughter
vessels at each node, which follows the generalized Murray’s law [31], [32]:
dβP = d
β
D,1 + d
β
D,2, (9)
where subscript P indicates the parent segment and subscripts D, 1 and D, 2 indicate the two daughter
segments at the same bifurcation. The exponent β is called the bifurcation exponent, which ranges from
2.0 to 3.0 and determines the fractal dimension of a vascular tree. According to [32], β is equal to
2.6 ∼ 2.7 for the human arterial vessels. For large arteries of systemic circulation β is around 2.33. For
capillaries β is near 3. The vessel length is proportional to its diameter:
L = Kd, (10)
where K is a constant for given vessels. For small arteries or capillaries K ≈ 60.
Vascular bifurcations often exhibit asymmetric structure such that the two branch diameters differ from
one junction to the other. Define the ratio of the two diameters
λ =
dD,2
dD,1
, dD,2 ≤ dD,1. (11)
For arterial vessels λ is in the range of 0.59 ∼ 0.83 [32]. Substituting (11) into (9) yields
dD,1
dP
=
1
(1 + λβ)
1/β
,
dD,2
dP
=
λ
(1 + λβ)
1/β
. (12)
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The self-similarity fractal dimension, DF , is defined as [31]
DF = ln 2
ln 2− ln (1 + λ2) + ln (1 + λβ)2/β
. (13)
Murray’s formula also describe the angle between two daughter vessels. Define θD,1 and θD,2 to be
the angles between daughter branch 1 and the parent segment, and daughter branch 2 and the parent.
The following relationships can be obtained [32]:
cos θD,1 =
d4P + d
4
D,1 − d4D,2
(2dP dD,1)
2 , cos θD,2 =
d4P + d
4
D,2 − d4D,1
(2dP dD,1)
2 . (14)
The total branch angle θD,1 + θD,2 between two daughter vessels after division is known as bifurcation
angle, which ranges between 75◦ and 90◦. The minimum angle 75◦ is obtained when the two daughter
branches are equal. Arterial branching angle falls roughly in the range of 60◦ ∼ 80◦. For capillaries this
angle is between 80◦ and 90◦.
Real-life physiological data exhibit a large amount of scatter in the values of vessel diameters or in the
values of bifurcation exponent [31]. This wide variability in branching data should be incorporated in the
simulation studies. Furthermore, as some capillaries are so slender that they can hardly be imaged, the
resolvable and unresolvable segments in the vascular network should be identified to represent a realistic
angiogram.
Based on the fractal character of vascular branching, we propose a random walk process on the vascular
tree as the baseline model for simulating the propagation of a TMS swarm. The algorithm involves the
following steps.
1) Let q0 = (x0, y0) represent the initial position of the swarm, which is determined by the injection
site and is assumed to be located on a root vessel with diameter dP,0 and length LP,0. The initial
direction is chosen to be aligned with the root vessel at q0. Generate a random bifurcation exponent
β0 and a random asymmetry ratio λ0, which are uniformly distributed in the intervals Iβ and Iλ,
respectively. These two intervals are dependent on the type of blood vessel. Let v(t) represent the
time-varying speed of the swarm, which depends on the propelling mechanism, the blood velocity,
and the blood pressure. Let i = 1.
2) At the ith bifurcation, calculate the diameters of two daughter segments, dD,i,1 and dD,i,2, by
substituting dP,i−1, βi−1, and λi−1 into (12). Calculate two junction branch angles θi,1 and θi,2, by
substituting dP,i−1, dD,i,1 and dD,i,2 into (14). Generate a binary random number Zi ∈ {0, 1} that
determines the branching direction (i.e., which of the two asymmetrical branches generated at the
ith bifurcation level has a larger diameter).
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3) At the ith bifurcation, generate a random vessel length LD,i,1, which has an exponential distribution
of mean KdD,i,1 [see also (10)]:
fLD,i,1 (LD,i,1) =
1
KdD,i,1
exp
(
− LD,i,1
KdD,i,1
)
. (15)
Similarly, generate another exponentially-distributed vessel length LD,i,2 with mean KdD,i,2. Subject
to a specific controlling strategy as to be discussed in Section IV, select the jth (j = 1, 2)
daughter segment to be the traveling path after the ith bifurcation. Define dP,i = dD,i,j and
LP,i = LD,i,j . Generate two random variables βi and λi, uniformly distributed in the intervals
Iβ and Iλ, respectively.
4) Check whether the TMS dissolve into the biofluid medium at the jth (j = 1, 2) branch. If the
answer is positive, stop the iteration. Otherwise, go to Step 5.
5) Check whether the jth (j = 1, 2) branch intersects the predefined receiving circular zone (tumor
microenvironment). If the answer is positive, record the first intersection point as the arrival position
of the swarm and stop the iteration. Otherwise, increment i by 1 and go to Step 2.
B. Transient Characteristics of TMS Swarm
We then consider the characteristic models for the transient kinetics of a TMS swarm, which can be
divided into three different components caused by three different mechanisms: diffusion, branching, and
degeneration. Each mechanism reduces certain percentage of the effective TMS in the swarm, and the
overall transience is characterized by the multiplicative effect of these three components. Similarly, we
first consider the situation that the vasculature is angiographically resolvable.
1) Diffusion: Based on experimental findings (see e.g., [20]), we assume that an agglomeration of
TMS are controlled like a unified organism to swim in the biofulid medium. The number of TMS for
each swarm will be typically large. It is thus convenient to deal with their count or concentration in
various volumes of space. The diffusion occurs in a controlled environment in one dimension (i.e., blood
vessel). Between the ith and (i + 1)th bifurcations, suppose that the TMS swarm moves in a blood
vessel whose cross-sectional area is AP,i = πd2P,i/4 and the inside wall of the vessel is impervious to
the TMS. As a coarse approximation, we could quantify the TMS diffusion with respect to the centroid
of the swarm by using the result in [35]:
Ui,k(l, t) =
ηQi,k
AP,i
√
πDt
exp
(
− l
2
4Dt
)
, (16)
where Qi,k is the number of TMS at the kth AZ between the ith and (i + 1)th bifurcations, D is the
diffusion coefficient of the biological medium in m2/sec, t is the propagation time, l is the distance
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between an arbitrary TMS and the centroid of the swarm, and η is a scaling factor accounting for the
discrepancy between the realistic propagation scenario in a blood vessel and the ideal case in an infinite
tube with a perfect reflecting barrier at the source end of the tube. Assume that there is some threshold
density U⋆ such that the MAU tracking the swarm responds to concentrations of U⋆ and greater. The
limit distance of the threshold volume is
l⋆i,k(t) =


√
4Dt ln ηQi,k
AP,iU⋆
√
πDt
for 0 ≤ t ≤
(
ηQi,k
AP,iU⋆
)2
1
πD ,
0 Otherwise.
(17)
This distance increases through time to a maximum, ηQi,kAP,iU⋆
√
2
πe , at time
(
ηQi,k
AP,iU⋆
)2
1
πDe , then decreases
to zero at which time the concentration is everywhere below threshold. The time of ultimate fade out is(
ηQi,k
AP,iU⋆
)2
1
πD .
Subsequently, when only the diffusion loss is considered, the amount of TMS at the (k + 1)th AZ is
obtained as
Qi,k+1 =
∫ min{l⋆i,k(ti,k,k+1),ℓi,k+1}
−min{l⋆i,k(ti,k,k+1),LP,i−ℓi,k+1}
AP,iUi,k (l, ti,k,k+1) dl
=
∫ min{l⋆i,k(ti,k,k+1),ℓi,k+1}
−min{l⋆i,k(ti,k,k+1),LP,i−ℓi,k+1}
ηQi,k√
πDti,k,k+1
exp
(
− l
2
4Dti,k,k+1
)
dl
= ηQi,k

erf

min
{
l⋆i,k(ti,k,k+1), ℓi,k+1
}
√
4Dti,k,k+1

+ erf

min
{
l⋆i,k(ti,k,k+1), LP,i − ℓi,k+1
}
√
4Dti,k,k+1




(18)
where ti,k,k+1 is the traveling time from the kth to (k + 1)th AZ, ℓi,k+1 is the distance between the
(k+1)th AZ and the ith bifurcation, and erf(·) is the Gauss error function. The superscript diff denotes
diffusion.
2) Branching: At the ith bifurcation (see also Fig. 3), when the parent and daughter blood vessels are
visible on the angiogram, an AZ at the entrance of the intended daughter branch can be set up to greatly
reduce the branching effect. In this case, we will ignore the branching loss in our simulation studies. On
the other hand, if the vessels are undetectable inside the human body due to the limit in sensitivity of the
imaging modality used, it is more difficult to maintain the convergence of TMS through a carefully set
AZ. One possible remedy is to reduce the distance between two successive AZs. This, however, may not
be practical in real-life applications due to constraint on drug delivery time. In the worst case, the ratio of
the amount of TMS entering two daughter segments is approximated as d2D,i,1/d2D,i,2 and the branching
attenuation is (assuming that the intended path is the 1st daughter vessel) ρmin = d2D,i,1/
(
d2D,i,1 + d
2
D,i,2
)
.
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The actual attenuation ρ ranges between ρmin and 1 depending on the displacement between neighboring
AZs, x. For simplicity, we postulate the following exponential relationship between ρ and x:
ρ(x) = (1− ρmin) exp
(
− x
x0
)
+ ρmin. (19)
The term x0 is the rate parameter, which is comparable to the length of the blood vessel.
3) Degeneration: This measure quantifies the effect of bioresorption, which is normalized such that
it ranges from 0 (no resorption) to 1 (complete resorption).
Following the experimental findings reported in [2], [3], in terms of a silicon-based TMS, the sys-
tem exhibits two-stage kinetics in its functional transience. For example, immersion of metal-oxide-
semiconductor field-effect transistors formed using silicon nanomembranes, silicon dioxide gate di-
electrics, and magnesium electrodes, with encapsulating layers of magnesium oxide and silk, in deionized
water for up to ∼90 hours caused small change in key device properties. Significant functional degradation
then occurred in a narrow time interval (<3 hours) after this period of stable operation. The encapsulation
defines the first time scale, whereas the magnesium electrodes define the second. A similar phenomenon
was found in the dissolution behavior of other diode devices [2], [3]. Furthermore, a transient bioresorbable
device for thermal therapy was implanted under the skin of a Sprague-Dawley rat. Inductive coupling
through the skin generated a localized temperature increase to sterilize and maintain asepsis at the wound
site. The functional transience had a time scale of 15 days, which was controlled via the crystallinity of
the silk package. After this time, the device quickly disappeared [3].
Consequently, to synthesize the two-stage kinetics as well as random bioresorbing, we model the
transient characteristics based on a dual-slope Le´vy process:
Ck =


1[0,1) (Ltk (Λ1))Ltk (Λ1) + 1[1,∞) (Ltk (Λ1)) if Ck−1 ∈ [0, C∗) ,
1[0,1) (Ltk (Λ2))Ltk (Λ2) + 1[1,∞) (Ltk (Λ2)) if Ck−1 ∈ [C∗, 1) ,
1 if Ck−1 = 1,
(20)
where C0 = 0 represents the initial condition at t0 = 0 when the TMS swarm has just been injected
without any bioresorption. Ck and tk (k = 1, 2, · · · ) are the transient characteristic and total duration of
immersion, respectively, when the TMS arrive at the kth AZ. Ltk (Λj) (j = 1, 2) satisfies the following
properties of a Le´vy process: (i) L0 = 0 almost surely; (ii) (independence of increments) for any 0 ≤
t1 < t2 < · · · < tk < ∞, Lt2 − Lt1 , Lt3 − Lt2 , · · · , Ltk − Ltk−1 are independent; (iii) (stationary
increments) for any s < t, Lt − Ls is equal in distribution to Lt−s; and (iv) (continuity in probability)
for any ǫ > 0 and t ≥ 0 it holds that limh→0 Pr (|Lt+h − Lt|) = 0. We consider the exponential process
where the probability distribution of Ltk(Λj) − Ltk−1(Λj) is an exponential distribution with expected
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value (tk − tk−1) /Λj . In the dual-slope Le´vy process, 0 < 1/Λ1 ≪ 1/Λ2 < ∞ are the rates of the
two-stage bioresorbing process. Note that the degeneration of TMS in the biofluid medium is irreversible
and therefore, Ck is a non-decreasing sequence. An indicator function 1A : L→ {0, 1} is defined as
1A(L) ,

 1 if L ∈ A,0 if L /∈ A. (21)
The indicator terms in (20) switch the value of Ck between Ltk (for 0 ≤ Ltk < 1) and 1 (for Ltk ≥ 1),
where the maximum value of 1 indicates complete bioresorption. Furthermore, the critical point C∗
determines the boundary of the two regimes of transient kinetics. Finally, the two parameters tF = Λ1C∗
and tP = Λ1C∗ + Λ2 (1− C∗) are the functional lifespan and physical lifespan of TMS, respectively.
In terms of a bacterial TMS (e.g., MTB), the degeneration process is related to decrease in its terminal
velocity. Initial experiments conducted in human blood at 37◦ showed that the velocity V (in µm/s) at a
time t (expressed in minutes) after the beginning of operations of the MTB decreased according to [19]
V = 0.0907t2 − 8.0966t + V0, (22)
where V0 is the initial average velocity of the MTB prior to being injected into blood. The MTB
would remain effective for a duration of ∼ 40 min, and the decrease in speed was probably caused
by the relatively high temperature of blood. The second-order polynomial regression model in (22) is not
convenient for simulation studies and theoretical analysis. Instead, we propose to use an exponentially
decaying function to approximate the swimming speed of MTB in blood:
V (t) = V0 exp
(
t
t0
)
, (23)
where t0 determines the decaying rate of speed with respect to time. To approximate the relationship in
(22), t0 is chosen to be around 15 minutes by visual inspection.
The swimming speeds from a large sample of MTB have been measured by Martel et al. with a video
camera mounted on an optical microscope in reflection-mode microscopy using dark-field illumination
[19]. Based on the observation in [19], we could model the terminal velocity distribution of the MTB
using a truncated Gaussian pdf with mean µV = V (t) and standard deviation σV ≈ 60 µm/s (i.e. without
a priori selection) or σV ≈ 20 µm/s (i.e. with a priori selection). As shown in [19], the minimum and
maximum speeds are given by Vmin = 0 µm/s and Vmax = 300 µm/s, respectively. Suppose that the
threshold velocity below which an MTB is deemed degenerated is Vth. The percentage of effective MTB
upon arrival at the kth AZ, where the total immersion time is tk, can be calculated as the probability
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that the random velocity of an arbitrary MTB, v, is less than Vth:
Ck = Pr (v ≤ Vth) =
erf
[
Vth−V (tk)√
2σ2V
]
− erf
[
Vmin−V (tk)√
2σ2V
]
erf
[
Vmax−V (tk)√
2σ2V
]
− erf
[
Vmin−V (tk)√
2σ2V
] (24)
C. Derivation of TouchCom Channel Parameters
When the TMS swarm reaches the targeted site, the percentage of drug consumed during the prop-
agation phase (i.e., the path loss) can be derived by accounting for the three transience mechanisms
mentioned above:
h0 =
SR
ST
=
I∏
i=0
Ki∏
k=0
Qi,k+1
Qi,k︸ ︷︷ ︸
diffusion
×
I∏
i=1
ρi︸ ︷︷ ︸
branching
×
(
1− CPI
i=0 Ki
)
︸ ︷︷ ︸
degeneration
,
(25)
where I is the total number of bifurcation, Ki is the number of AZs at the ith bifurcation, and the KIth
AZ is the tumor microvasculature as shown in Fig. 3. Q0,0 = ST denotes the initial number of TMS.
Furthermore, Qi,Ki = Qi+1,0 for i = 0, 1, · · · , I − 1. Substituting (18)-(20) and (24) into (25) yields
the overall path loss. The overall delay τ is given by the submission of all propagation delays between
consecutive AZs as well as the tracking times at these zones. Furthermore, as illustrated in Fig. 3, the
incident angle ϕ is defined as the angle between the line joining the center of the receiving circular
zone (tumor microvasculatre) and the point where the TMS path intersects the receiving zone and the
horizontal axis.
D. Simulation Models for Angiographically Unresolvable Vasculature
When the blood vessels are too tiny to be imaged, the vascular network could be approximated as a
homogeneous fluid medium. Subsequently, the movement of the TMS swarm can be modeled using a
velocity-jump random walk process [4]. We assume that the swarm moves forward with a time-varying
speed for a time step of random length, which is governed by a Poisson process with turning frequency ̟.
Hence, the mean run length time is 1/̟. The swarm then changes its direction, with the new direction
(angle) generated via the von Mises pdf, which has been commonly employed in the simulation of
correlated random walks for the distribution of turning angle at each step [36]. The mean of this pdf
depends on the propelling field at the present location of the swarm and thus introduces a directional
bias. Our movement simulation algorithm involves the following steps:
July 26, 2014 DRAFT
SUBMITTED TO IEEE TRANSACTIONS ON NANOBIOSCIENCE 16
1) Let qˆ0 = (xˆ0, yˆ0) represent the initial position of the swarm, which is determined by the location
where it enters the unresolvable zone on the angiogram. The initial direction is chosen to be aligned
with the external field at qˆ0. Let v(t) represent the speed of the swarm, ̟ the turning rate, and κ
the concentration parameter of the von Mises velocity (direction) jump. Let i = 0.
2) Obtain a random time step ∆ti as a result of a Poisson process of intensity ̟. Consequently, ∆ti
follows an exponential distribution of mean 1/̟, with pdf
f∆ti (∆ti) = ̟ exp(−̟∆ti). (26)
Obtain a random angle ∆θi from the von Mises distribution of mean 0 and concentration κ, using
an envelope-rejection method based on a wrapped Cauchy distribution [37]. The pdf is given by
f∆θi (∆θi) =
1
2πI0(κ)
exp(κ cos∆θi), (27)
where I0 denotes the modified Bessel function of the first kind and order 0. The distribution is
unimodal and is symmetrical about 0. The mode is at θ = 0 and the width of the angular spread
is controlled by κ. For κ = 0, the pdf is equal to the uniform distribution; while κ → ∞ yields a
sharply peaked distribution about 0.
3) Obtain the new position qˆi+1 = (xˆi+1, yˆi+1) from the old position qˆi = (xˆi, yˆi), given ∆ti and ∆θi
generated in Step 2, using the simple trigonometry as follows:
xˆi+1 = xˆi +
[∫ ∆ti
0
v(t; i)dt
]
cos (θi +∆θi) (28)
and
yˆi+1 = yˆi +
[∫ ∆ti
0
v(t; i)dt
]
sin (θi +∆θi) , (29)
where θi is the angle of the external field at qˆi.
4) Increment i by 1 and go to Step 2, unless a stopping condition is reached (e.g., the swarm dissolves
into the blood or reaches the tumor microenvironment).
The next step is to characterize the transient behavior of the TMS swarm. Firstly, the diffusion and
branching effects can be combined into a two-dimensional diffusion process with respect to the centroid
of the swarm [35]:
U(r, t) =
Q
4πDt
exp
(
− r
2
4Dt
)
, (30)
where Q is the amount of TMS at the origin, D is the diffusion coefficient of the biological medium in
m2/sec, t is the propagation time, and r is the distance between an arbitrary TMS and the centroid of
the swarm. Similar to (17), assume that there is some threshold density U⋆ such that the MAU tracking
July 26, 2014 DRAFT
SUBMITTED TO IEEE TRANSACTIONS ON NANOBIOSCIENCE 17
the TMS responds to concentrations of U⋆ and greater. The line of concentration of U⋆ at time t is a
circle with center at the centroid and radius
r⋆(t) =


√
4Dt ln Q4πDtU⋆ if 0 ≤ t ≤ Q4πDU⋆ ,
0 Otherwise.
(31)
Subsequently, the average number of TMS at the kth AZ is obtained as
Qk ≈
∫ r⋆(tk)
0
2πrU (r, tk) dr
=
∫ r⋆(tk)
0
Qr
2Dtk
exp
(
− r
2
4Dtk
)
dr
= Q
{
1− e−
[r⋆(tk)]
2
4Dtk
} (32)
where tk is the propagation time from the moment the swarm enters the unresolvable region to the kth
AZ in the region. Eq. (32) ignores the TMS diffusion loss outside AZs and assumes that the time spent
in traveling from one zone to another is much longer than the time spent at each zone.
In terms of the degeneration loss, the same models as those in (20)-(24) can be applied.
IV. COGNITIVE ENGINE FOR TOUCHCOM
For the proposed TouchCom framework, the external MAU is able to decide partially the propagation
path of TMS. On the other hand, the movement of TMS is influenced by the unknown in vivo environment
under surveillance. Furthermore, perception about the structure of blood vessels may change as further
knowledge on the vascular structure is acquired by observing the movement of TMS. This in turn, will
affect the trajectory planning in the next round of TMS maneuver. This feedback loop motivates adoption
of the cognitive engine as shown in Fig. 4. The engine applies previous measurements of the TMS path
(“environment”), and intelligently optimizes the planning of TMS pathway (“control”), in response to the
perceived surveillance environment variation such as the structure of the vascular network (“perception”)
in real time. The feedback loop from the tracking module to the propelling field source (“feedback”)
facilitate such a learning process. In this way, a visual display of communication channel is provided,
which enables the external MAU to control the movement of TMS by “touching” the tangible TMS-
maneuvering space with a guiding force.
In general, there are two criteria for TMS path planning. The first criterion aims at minimizing the
propagation delay from the injection site to the tumor microenvironment. The second criterion attempts to
minimize the attenuation loss of TMS-assisted drug delivery. Depending on the structure of vasculature,
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Fig. 4. Cognitive engine for TouchCom.
these two criteria may not always lead to a unique solution. For simplicity, the following heuristic rules
for the cognitive engine are proposed in line with the two criteria mentioned above.
1) When blood vessels are resolvable on the angiogram, the control process only occurs at each bifur-
cation. The cognitive engine chooses the daughter segment that results in the shorter perpendicular
distance from the center of the tumor microenvironment to the segment as the traveling path after
the bifurcation.
2) When blood vessels are unresolvable on the angiogram, a two-step control is required after the TMS
swarm leaves the previous AZ and is about to reach the next AZ. First, the cognitive engine identifies
the area with the highest concentration of TMS as the next AZ. Subsequently, the direction of the
guiding field is chosen to be aligned with the line connecting the centers of the AZ and the tumor
microenvironment.
These two heuristic rules can be readily integrated into the simulation steps mentioned in Section III.
V. NUMERICAL EXAMPLES
We present a study case of TouchCom for silicon-based TMS assuming an external propelling field is
employed to guide the TMS for targeted drug delivery. We assume that the speed of the TMS swarm
is 0.03 cm/s, comparable to the average velocity of blood flow in capillaries. The time spent at each
AZ is assumed to be negligible as compared to the propagation time. The injection site is located at the
origin. The tumor microenvironment is a circular area centered at (10 cm, 0 cm) and having a radius
of 0.5 cm. The diameter and length of the root vessel where the TMS swarm is injected are 0.1 cm
and 1 cm, respectively, and the vessel is aligned with the x−axis. The angiographically unresolvable
vasculature Vur is the region defined by x ≥ xr, whereas the angiographically resolvable region Vr is
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defined by x ≤ xr. In the simulation studies, we will consider three different widths of the resolvable
region: xr = 4, 6, 8 cm.
To synthesize the movement of TMS in Vr, the bifurcation exponent and asymmetric ratio of the
vascular tree are set to be uniformly distributed in [2.6, 2.7] and [0.6, 0.8], respectively. The length-to-
diameter ratio K is 40. In terms of the movement of TMS in Vur, the following model parameters
are used: ̟ = 0.1 s−1 and κ = 2. To model the path loss, the degeneration parameters are given
by Λ1 = 20 min, Λ2 = 2 min, and C∗ = 0.5. We will consider three different diffusion coefficients
D = 10−6, 10−7, 10−8 m2/s.
Fig. 5 illustrates a typical path of the TMS swarm when the boundary of angiographically resolvable
vasculature and the diffusion coefficient are set to be xr = 6 cm and D = 10−7 m2/s, respectively. As
can be seen from this figure, the trajectory in Vr has longer and more regular segments as compared to
Vur. Fig. 6 shows the degeneration, diffusion, and overall losses corresponding to the trajectory in Fig.
5. Note that the attenuation caused by diffusion increases abruptly as the TMS swarm enters Vur. On
the other hand, the degeneration loss increases gradually throughout the entire transportation process.
The empirical distribution of propagation time from the injection site to the tumor, the pdf of angle-
of-arrival at the tumor, and the pdf of path loss for three different values of the diffusion coefficient D
are shown in Fig. 7(a)-(c) based on 50000 simulation runs. Furthermore, the delay spectrum and azimuth
spectrum are depicted in Fig. 7(d)-(e). As can be seen from Figs. 7(a) and 7(d), both the pdf of delay
and delay spectrum first increase with delay and reach their maximum values. Then, the pdfs decrease
and exhibit a long tail. The pdfs of time-of-arrival are concentrated within a broader temporal range
as compared to the delay spectrum. Furthermore, various D do not lead to noticeable changes in the
former plots, whereas a larger D results in smaller delay spreads in the latter plots. Next, the pdf of
path loss is featured by a clustering phenomenon as shown in Fig. 7(c). It exhibits a peak at around
0 (i.e., the amount of drug delivered is completely attenuated), together with an asymmetric cluster for
larger values of path loss. As D decreases, the chance of successfully delivering more drug molecules
increases. Finally, as illustrated in Figs. 7(b) and 7(e), both the pdf of azimuth and azimuth spectrum are
symmetric with respect to 0◦. The value of D has a negligible effect on the pdf of angle-of-arrival, but
has a remarkable effect on the azimuth spectrum.
We then look into the influence of different sizes of the angiographically resolvable region on the
distributions. As shown in Fig. 8, all the plots except for the pdf of path loss are insensitive to the
change in xr. Nevertheless, a larger xr increases the chance of transporting a larger amount of drug
cargoes to the tumor microenvironment.
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Fig. 5. Simulated TMS trajectory for the diffusion coefficient D = 10−7 m2/s and the boundary of regions xr = 6 cm.
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Fig. 6. Path loss for the diffusion coefficient D = 10−7 m2/s and the boundary of regions xr = 6 cm.
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Fig. 7. Pdfs of (a) delay, (b) angle-of-arrival, and (c) path loss; (d) delay spectrum and (e) azimuth spectrum for three different
values of diffusion coefficients D. In all cases, the boundary of regions xr = 6 cm.
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Fig. 8. Pdfs of (a) delay, (b) angle-of-arrival, and (c) path loss; (d) delay spectrum and (e) azimuth spectrum for three different
boundaries of angiographically resolvable vasculature xr. In all cases, the diffusion coefficient D = 10−7 m2/s.
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VI. CONCLUSION
We have proposed a TMS-assisted TouchCom model for targeted drug delivery, and analyzed the
system architecture and simulation tools of the proposed framework. We have also presented numerical
examples to demonstrate the principles of our approach. Specifically, we have investigated the distributions
of the delay, angle-of-arrival, and path loss, as well as the delay spectrum and azimuth spectrum, which
are important parameters from the perspectives of both drug delivery and information exchange. The
TouchCom paradigm represents a unified framework that integrates robotics and communications “at
the bottom”, and establishes the useful analogy between the TMS-based drug delivery and small-scale
communications.
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